Vesatolimod

维沙莫德

Report date: 2025/05/12 15:27:11
NME

Base Information

Drug NameVesatolimod
Drug Alias Name维托莫德vesatolimodumGS-9620O8M467C50G
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsHepatitis CHepatitis B, ChronicHepatitis B +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[14] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGilead Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences Inc
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Inactive IndicationsHepatitis CHepatitis B, ChronicHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A